Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Bill Ackman, Steven A. Cohen, Tom Steyer, RA Capital Management, Healthequity Inc (HQY), Tel-Instrument Electronics Corp. (TIKK), and More

A Director at Tel-Instrument Electronics (Other OTC: TIKK) is Selling Shares (Analyst Ratings)
Today, a Director at Tel-Instrument Electronics (TIKK), Robert Rice, sold shares of TIKK for $13.05K. Based on Tel-Instrument Electronics’ latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $4.1 million and quarterly net profit of $501.1K. In comparison, last year the company earned revenue of $1.81 million and had a GAAP net loss of $746.1K. Currently, Tel-Instrument Electronics has an average volume of 300.

Eyenovia Inc (EYEN) CEO Tsontcho Ianchulev Bought $650,000 of Shares (Guru Focus)
CEO of Eyenovia Inc (30-Year Financial, Insider Trades) Tsontcho Ianchulev (insider trades) bought 233,813 shares of EYEN on 07/11/2019 at an average price of $2.78 a share. The total cost of this purchase was $650,000. Eyenovia Inc is a clinical stage biopharmaceutical company. It is engaged in developing a pipeline of ophthalmology products utilizing patented piezo-print technology to deliver micro-therapeutics topically to the eye. Eyenovia Inc has a market cap of $35.910 million; its shares were traded at around $2.98.

Tuesday 7/16 Insider Buying Report: HQY, FDX (Nasdaq.com)
On Friday, HealthEquity (HQY)’s Founder and Vice Chairman, Stephen Neeleman, made a $610,000 buy of HQY, purchasing 10,000 shares at a cost of $61.00 each. So far Neeleman is in the green, up about 16.4% on their purchase based on today’s trading high of $70.99. HealthEquity is trading trading flat on the day Tuesday. This buy marks the first one filed by Neeleman in the past year. And at FedEx Corp (FDX), there was insider buying on Friday, by Director John C. Inglis who bought 600 shares at a cost of $167.69 each, for a trade totaling $100,614. FedEx Corp is trading up about 2.5% on the day Tuesday. So far Inglis is in the green, up about 3.0% on their purchase based on today’s trading high of $172.66.

Nairobi Regulators Crack Down on Insider Trading (TheAfricaReport.com)
Kenya’s capital markets regulator fined three stockbrokers and suspended them for one and three years, in a high-profile insider trading case that threatened to derail the takeover of a listed oil company. Andre DeSimone, former CEO and executive director of Kestrel Capital, was fined KSh2.5m ($24,250) and suspended from holding any key office in a public company for one year. Renown stockbroker and financial analyst Aly-Khan Satchu ceded KSh4.7m he had received as commissions, and was suspended from the capital markets for three years. Another stockbroker, Kunal Bid, gave up KSh23.4m in commissions earned from transactions he made through two agents.

Penumbra Inc (PEN) Chairman, CEO and President Adam Elsesser Sold $1.4 million of Shares (Guru Focus)
Chairman, CEO and President of Penumbra Inc (30-Year Financial, Insider Trades) Adam Elsesser (insider trades) sold 8,000 shares of PEN on 07/11/2019 at an average price of $171.84 a share. The total sale was $1.4 million. Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures. Penumbra Inc has a market cap of $6 billion; its shares were traded at around $172.73 with a P/E ratio of 575.79 and P/S ratio of 13.56. GuruFocus has detected 2 severe warning signs with Penumbra Inc.

Insider Trading: July 16, 2019 (BIV.com)
Insider:  Frank Giustra, Director. Company:  Leagold Mining Corp. (TSX:LMC). Shares owned:  1,446,500. Trade date:  July 4, 5, 8, 9. Trade total:  $610,260. Trade:  Acquisition of 301,500 shares at prices ranging between $2 and $2.04 per share.